• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hyperkinesis

Hyperkinesis - 21 Studies Found

Completed : Classroom-Level Intervention to Promote Peers' Acceptance of Children With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder
: 2010-05-10
:
  • Behavioral: Behavioral contingency management

Completed : Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder
: Attention Deficit Hyperactivity Disorder
: 2007-01-04
: Drug: GTS21/Placebo
Withdrawn : A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving Simulators
: Attention Deficit Hyperactivity Disorder
: 2007-04-02
: Drug: SPD465
Completed : Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment
: Attention Deficit Hyperactivity Disorder
: 2015-10-26
:
  • Behavioral: Brain Training (Active)

Completed : Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury
: Paroxysmal Sympathetic Hyperactivity
: 2016-05-23
:
  • Other: Musical intervention
  • Other: Control

Completed : A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
: Attention Deficit Hyperactivity Disorder
: 2006-05-12
: Drug: methylphenidate hydrochloride extended-release tablets
Completed : Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
: Attention-Deficit/Hyperactivity Disorder
: 2008-05-28
: Drug: ABT-089 Subjects will take up to 80 mg daily for 24 months
Completed : Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment
: "Attention Deficit Hyperactivity Disorder"
: 2013-09-15
:
  • Drug: Ritalin Patients with AD

Completed : Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight's Doses
: Neurogenic Vesical Hyperactivity Syndrom
: 2016-06-24
:
  • Drug: full dose at 16 UI/kg for Dysport or 6,5 UA/kg for Botox

Completed : Adult Attention Deficit Hyperactivity Disorder
: Adult Attention Deficit Hyperactivity Disorder
: 2012-09-18
:
  • Drug: SEP-225289 SEP-225289 4m

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.